These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28382651)

  • 1. Editorial: A New Classification of Adult Autoimmune Myositis.
    Senécal JL; Raynauld JP; Troyanov Y
    Arthritis Rheumatol; 2017 May; 69(5):878-884. PubMed ID: 28382651
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory myopathies: Adult and paediatric experts unite for new response criteria.
    Collison J
    Nat Rev Rheumatol; 2017 Jun; 13(6):321. PubMed ID: 28469265
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of myositis-specific antibodies.
    Vulsteke JB; De Langhe E; Claeys KG; Dillaerts D; Poesen K; Lenaerts J; Westhovens R; Van Damme P; Blockmans D; De Haes P; Bossuyt X
    Ann Rheum Dis; 2019 Jan; 78(1):e7. PubMed ID: 29371203
    [No Abstract]   [Full Text] [Related]  

  • 4. The balance between clinical convenience and the new concepts of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Kim HS
    Korean J Intern Med; 2021 Mar; 36(2):288-291. PubMed ID: 33725435
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to: 'Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice' by Hočevar
    Lundberg IE; Bottai M; Tjärnlund A
    Ann Rheum Dis; 2018 Dec; 77(12):e91. PubMed ID: 29317406
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: 'Detection of myositis-specific antibodies' by Vulsteke
    Tjärnlund A; Rönnelid J; Bottai M; Lundberg IE
    Ann Rheum Dis; 2019 Jan; 78(1):e8. PubMed ID: 29382639
    [No Abstract]   [Full Text] [Related]  

  • 7. External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies.
    Luu Q; Day J; Hall A; Limaye V; Major G
    Ann Rheum Dis; 2022 Apr; 81(4):e59. PubMed ID: 32398280
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
    J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to personalize the treatment of anti-MDA-5 associated lung disease.
    Lake M; George G; Summer R
    Ann Rheum Dis; 2019 Jun; 78(6):e52. PubMed ID: 29643107
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of myositis-specific antibodies: additional notes.
    Mahler M; Fritzler MJ
    Ann Rheum Dis; 2019 May; 78(5):e45. PubMed ID: 29444906
    [No Abstract]   [Full Text] [Related]  

  • 11. [On polymyositis, myositis and dermatomyositis, with report of 4 clinical cases].
    Crisalli M; Chiossi FM; Castellani R; Lavia G
    Minerva Pediatr; 1973 Jan; 25(1):33-42. PubMed ID: 4687105
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
    Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S
    Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questions pertaining to the etiology and pathophysiology of polymyositis/dermatomyositis.
    Sontheimer RD; Ziff M
    Clin Dermatol; 1988; 6(2):105-19. PubMed ID: 3293738
    [No Abstract]   [Full Text] [Related]  

  • 18. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy screening in autoimmune myositis among Australian rheumatologists.
    Dutton K; Soden M
    Intern Med J; 2017 Dec; 47(12):1367-1375. PubMed ID: 28742270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of myositis-specific antibodies: additional notes.
    Infantino M; Manfredi M; Grossi V; Benucci M
    Ann Rheum Dis; 2019 Apr; 78(4):e29. PubMed ID: 29535123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.